Last month, Matteo Morello, MD and Bethany Gholson won the Research Investigator Awards at the 2025 American Society of Echocardiography conference! Congratulations to you both! Read more: cvrc.virginia.edu/ase-2025/

💉 Intrapericardial Bleomycin: A Promising Option for Malignant Pericardial Effusion pubmed.ncbi.nlm.nih.gov/40729502 Waqas Haider, MD, MPH, FACC #CardioOncology #PericardialEffusion #CancerCare #TargetedTherapy #Pharmacology

Glad to contribute to this editorial with Aldo Bonaventura on Peripartum cardiomyopathy. A paradox where the joy of birth can turn into a fight for life. internationaljournalofcardiology.com/article/S0167-…

This was a great study to work on, not least because it involved 11 Centres in 6 countries 🤝🦠❤️‍🔥 Cardiovascular and Metabolic Medicine & Sciences King's Faculty of Life Sciences & Medicine HFAPresident

So happy to have found the original article from 1952 that explained the importance of early mobilization in patients with heart attacks (from 6-week bedrest to rapidly moving to a chair has saved millions of lives)

Targeting the NLRP3 inflammasome to reduce CV risk!! UVA CVRC Stefano Toldo Benjamin Van Tassell

Have you ever heard of lipid stability? It’s not just about lowering LDL-C, it’s about keeping it stable over time. Less variability = better cardiovascular outcomes. Analysis by Arturo Cesaro from University of Campania “L.Vanvitelli” - Naples (Italy) lnkd.in/d_KNaSnU

It’s well known that the immune response after MI can be a double-edged sword. Blocking CD14 at reperfusion can turn down that harmful inflammation, protect the heart and prevent remodeling, without immunosuppression! AntonioAbbate Benjamin Van Tassell Michele Marchetta Marco Del Buono

2025: ↑ more cardiac procedures = ↑ more post-cardiac injury syndrome. Imaging (echo, CT and MRI) + Interleukin (IL)-1 blockers (anakinra, rilonacept) can change the game, especially when NSAIDs + colchicine aren’t enough. 10.1016/j.jacadv.2025.102166

AQUATIC Trial: 872 adults with CCS + prior stent + high residual atherothrombotic risk on OACs for any reasons (~90% for AFib) Adding aspirin (100 mg) to OACs seems to increase harm without a clear ischemic benefit compared to placebo. 10.1056/NEJMoa2507532

📢 New publication in Reviews in Cardiovascular Medicine Reviews in Cardiovascular Medicine 👉 Vitamin D and Cardiovascular Disease: The Good, the Bad, and the Unknown 🩺 The Good: Vitamin D may help regulate vascular tone, inflammation, and myocardial remodeling, with possible anti-inflammatory

#Takotsubo cardiomyopathy triggered by cardioversion 🫀Builds on our systematic review of TTS and cardiac ropture 📷 linkinghub.elsevier.com/retrieve/pii/S… #Cardiology #Electrophysiology # takotsubo

Proud to be co-leading this exciting analysis with my good friend Austin Hogwood, PhD Anakinra and exercise capacity in HF across age groups! AntonioAbbate Benjamin Van Tassell Francesco Moroni, MD Marco Del Buono

"Collaboration fuels discovery." Paola Pastena, MD Luigi Spadafora Stefano Cacciatore, MD Arturo Cesaro FrancescaDiMuro SABOURETCardiologist Francesco Perone Reviews in Cardiovascular Medicine

#AHA2025 - looking forward to IL-1 Blockade in Patients With STEMI: a Pooled Analysis of Randomized Clinical Trials of Anakinra and Goflikicept | Circulation ahajournals.org/doi/abs/10.116… UVA CVRC VCU Health Pauley Heart Center VCU School of Pharmacy Michele Golino Benjamin Van Tassell Paul Cremer MD Angela Taylor

Presented at #AHA25: In patients with atrial fibrillation and a drug-eluting stent placed at least 1 year earlier, monotherapy with a non–vitamin K antagonist oral anticoagulant was noninferior to combination therapy with clopidogrel for net adverse clinical events. Full ADAPT

Excited to present this study on behalf of all my outstanding co-authors. Monday Nov 10 at 9.45am in New Orleans #AHA2025 AHA Science

#AHA2025 “These initial results are promising for a patient population that is too often misdiagnosed and live with difficult, even dangerous, symptoms..”

American Heart #25 beats in New Orleans, LA: Research, passion, friendship… and Bourbon St!

For the first time at a cardiology conference (#AHA25), you can get both Lp(a) and hsCRP tested. Inflammation awareness is finally taking off! Love to see it! AntonioAbbate Benjamin Van Tassell #inflammation #Lp(a) #hsCRP #AHA25